Raymond James Financial Inc. Makes New Investment in Masimo Co. (NASDAQ:MASI)

Raymond James Financial Inc. bought a new stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 203,971 shares of the medical equipment provider's stock, valued at approximately $33,716,000. Raymond James Financial Inc. owned approximately 0.38% of Masimo at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in MASI. Assetmark Inc. increased its position in shares of Masimo by 12.7% during the third quarter. Assetmark Inc. now owns 1,183 shares of the medical equipment provider's stock worth $158,000 after acquiring an additional 133 shares during the period. Crossmark Global Holdings Inc. increased its holdings in Masimo by 14.4% during the third quarter. Crossmark Global Holdings Inc. now owns 3,248 shares of the medical equipment provider's stock valued at $433,000 after buying an additional 409 shares during the period. State of New Jersey Common Pension Fund D increased its holdings in Masimo by 1.2% during the third quarter. State of New Jersey Common Pension Fund D now owns 16,736 shares of the medical equipment provider's stock valued at $2,231,000 after buying an additional 194 shares during the period. Oppenheimer Asset Management Inc. purchased a new position in Masimo in the third quarter worth $478,000. Finally, KBC Group NV lifted its stake in shares of Masimo by 17.3% during the third quarter. KBC Group NV now owns 1,280 shares of the medical equipment provider's stock worth $171,000 after buying an additional 189 shares during the period. Institutional investors own 85.96% of the company's stock.

Masimo Stock Down 1.2 %

MASI stock opened at $165.69 on Friday. The stock has a market capitalization of $8.94 billion, a P/E ratio of 114.27 and a beta of 1.03. The firm has a 50-day simple moving average of $174.90 and a 200-day simple moving average of $157.02. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50. Masimo Co. has a 52 week low of $101.61 and a 52 week high of $194.88.

Remove Ads

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.38. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The company had revenue of $600.70 million during the quarter, compared to analysts' expectations of $593.35 million. Equities analysts forecast that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Piper Sandler lifted their price objective on shares of Masimo from $210.00 to $215.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Needham & Company LLC restated a "hold" rating on shares of Masimo in a research report on Wednesday, February 26th. Wells Fargo & Company boosted their target price on shares of Masimo from $193.00 to $205.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Raymond James boosted their target price on shares of Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a research report on Friday, December 27th. Finally, Stifel Nicolaus restated a "buy" rating and set a $190.00 target price (up from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $194.80.

Insider Buying and Selling at Masimo

In other Masimo news, COO Bilal Muhsin sold 30,000 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $167.49, for a total value of $5,024,700.00. Following the transaction, the chief operating officer now directly owns 24,172 shares in the company, valued at $4,048,568.28. The trade was a 55.38 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 9.70% of the stock is currently owned by company insiders.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.